MICROBIOME ORAL CARECommercialization ready
DENTAL-BIO™
Microbiome-oriented oral care platform.
- Product family
- 3 complementary formats
- Planned market availability
- Q4 2026
- Seeking
- Distribution Partners
ACS Biomed / Portfolio
COMMERCIALIZATION-READY PORTFOLIO 2026
Alongside its pharmaceutical and medical technology pipeline, ACS Biomed is developing differentiated healthcare platforms whose formulations and positioning have already been defined and which are entering the next phase of sampling, industrialization and commercial development.
ACS ORAL HEALTH
WATER-FREE, MUCOADHESIVE ORAL-HEALTH TECHNOLOGYIn development
ADVANCED ORAL GEL PLATFORM
A next-generation oral-gel platform under development combining water-free formulation technology, mucoadhesive delivery and microbiome-focused functional components.
- Product family
- 2 development configurations
- Seeking
- Industrial and distribution partners
ACS WOMEN’S HEALTH
WOMEN’S VITALITY SYSTEMCommercialization ready
ENERGYNE™
Women’s vitality platform segmented by life stage.
- Product family
- 3 complementary references
- Planned market availability
- Q1 2027
- Seeking
- Distribution Partners
INTIMATE HEALTH & WELLNESSCommercialization ready
ACS WOMEN’S INTIMATE CARE
Specialist system for women’s intimate wellbeing.
- Product family
- 3 complementary references
- Planned market availability
- Q1 2027
- Seeking
- Distribution Partners
ACS JOINT & MOBILITY
JOINT & MOBILITYCommercialization ready
ARTHOFLEX™
Functional topical platform for everyday mobility and comfort.
- Product family
- 3 complementary references
- Planned market availability
- Q4 2026
- Seeking
- Distribution Partners
ACS MEN’S HEALTH
MEN’S VITALITY SYSTEMCommercialization ready
MACA PLUS™
Multi-active platform for men’s vitality across different life stages.
- Product family
- 3 complementary references
- Planned market availability
- Q1 2027
- Seeking
- Distribution Partners
